Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness (Q35010424)

5 August 2017

title

Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness (English)

1 reference

5 August 2017

0 references

Brian G Oliver

0 references

Judith L Black

1 reference

5 August 2017

Janette K Burgess

1 reference

5 August 2017

Sarah Boustany

1 reference

5 August 2017

Lyn M Moir

1 reference

5 August 2017

Markus Weckmann

1 reference

5 August 2017

Justine Y Lau

1 reference

5 August 2017

Karryn Grafton

1 reference

5 August 2017

Melissa Baraket

1 reference

5 August 2017

Philip M Hansbro

1 reference

5 August 2017

Nicole G Hansbro

1 reference

5 August 2017

Paul S Foster

1 reference

5 August 2017

language of work or name

English

0 references

publication date

29 October 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

5 August 2017

published in

1 reference

5 August 2017

volume

181

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

106-115

1 reference

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Determinants of endothelial cell phenotype in venules

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Provocation with adenosine 5'-monophosphate increases sputum eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Assessing the evidence for remodelling of the airway in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Following the TRAIL to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Asthma: a disease remodeling the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Requirement for IL-13 independently of IL-4 in experimental asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Interleukin-13: central mediator of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Airway smooth muscle cell proliferation is increased in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Cyclosporine A mediates fibroproliferation through epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Immunostimulatory DNA inhibits allergen-induced peribronchial angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

SPECIFIC STAINING OF SULPHATE GROUPS WITH ALCIAN BLUE AT LOW pH

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Staining of basement membranes and assocated structures by the periodic acid-Schiff and periodicacid-silver methenamine techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

The renal lesions of Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Angiogenesis and remodeling of airway vasculature in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Distinct antitumor properties of a type IV collagen domain derived from basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

IL-4 receptor signaling in Clara cells is required for allergen-induced mucus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

The role of IL-13 in established allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

The "classical" ovalbumin challenge model of asthma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0631OC

10.1164/RCCM.200904-0631OC

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference